Copyright Reports & Markets. All rights reserved.

Global Tiapride Hydrochloride Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tiapride Hydrochloride Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 100mg
    • 1.3.3 50mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tiapride Hydrochloride Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Tiapride Hydrochloride Tablets Market Size & Forecast
    • 1.5.1 Global Tiapride Hydrochloride Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Tiapride Hydrochloride Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Tiapride Hydrochloride Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Astellas Pharma
    • 2.1.1 Astellas Pharma Details
    • 2.1.2 Astellas Pharma Major Business
    • 2.1.3 Astellas Pharma Tiapride Hydrochloride Tablets Product and Services
    • 2.1.4 Astellas Pharma Tiapride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Astellas Pharma Recent Developments/Updates
  • 2.2 Nihon Generic
    • 2.2.1 Nihon Generic Details
    • 2.2.2 Nihon Generic Major Business
    • 2.2.3 Nihon Generic Tiapride Hydrochloride Tablets Product and Services
    • 2.2.4 Nihon Generic Tiapride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Nihon Generic Recent Developments/Updates
  • 2.3 Sawai Pharmaceutical
    • 2.3.1 Sawai Pharmaceutical Details
    • 2.3.2 Sawai Pharmaceutical Major Business
    • 2.3.3 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Product and Services
    • 2.3.4 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sawai Pharmaceutical Recent Developments/Updates
  • 2.4 Tasly Pharmaceuticals
    • 2.4.1 Tasly Pharmaceuticals Details
    • 2.4.2 Tasly Pharmaceuticals Major Business
    • 2.4.3 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Product and Services
    • 2.4.4 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Tasly Pharmaceuticals Recent Developments/Updates
  • 2.5 Grand Pharmaceutical
    • 2.5.1 Grand Pharmaceutical Details
    • 2.5.2 Grand Pharmaceutical Major Business
    • 2.5.3 Grand Pharmaceutical Tiapride Hydrochloride Tablets Product and Services
    • 2.5.4 Grand Pharmaceutical Tiapride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Grand Pharmaceutical Recent Developments/Updates
  • 2.6 Jiangsu Nhwa Pharmaceutical
    • 2.6.1 Jiangsu Nhwa Pharmaceutical Details
    • 2.6.2 Jiangsu Nhwa Pharmaceutical Major Business
    • 2.6.3 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Product and Services
    • 2.6.4 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
  • 2.7 Tianjin Pharmaceutical Da Ren Tang Group
    • 2.7.1 Tianjin Pharmaceutical Da Ren Tang Group Details
    • 2.7.2 Tianjin Pharmaceutical Da Ren Tang Group Major Business
    • 2.7.3 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Product and Services
    • 2.7.4 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments/Updates

3 Competitive Environment: Tiapride Hydrochloride Tablets by Manufacturer

  • 3.1 Global Tiapride Hydrochloride Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Tiapride Hydrochloride Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Tiapride Hydrochloride Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Tiapride Hydrochloride Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Tiapride Hydrochloride Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Tiapride Hydrochloride Tablets Manufacturer Market Share in 2025
  • 3.5 Tiapride Hydrochloride Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Tiapride Hydrochloride Tablets Market: Region Footprint
    • 3.5.2 Tiapride Hydrochloride Tablets Market: Company Product Type Footprint
    • 3.5.3 Tiapride Hydrochloride Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tiapride Hydrochloride Tablets Market Size by Region
    • 4.1.1 Global Tiapride Hydrochloride Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Tiapride Hydrochloride Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Tiapride Hydrochloride Tablets Average Price by Region (2021-2032)
  • 4.2 North America Tiapride Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.3 Europe Tiapride Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Tiapride Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.5 South America Tiapride Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Tiapride Hydrochloride Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Tiapride Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Tiapride Hydrochloride Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Tiapride Hydrochloride Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Tiapride Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Tiapride Hydrochloride Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Tiapride Hydrochloride Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Tiapride Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Tiapride Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Tiapride Hydrochloride Tablets Market Size by Country
    • 7.3.1 North America Tiapride Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Tiapride Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Tiapride Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Tiapride Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Tiapride Hydrochloride Tablets Market Size by Country
    • 8.3.1 Europe Tiapride Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Tiapride Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tiapride Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Tiapride Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Tiapride Hydrochloride Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Tiapride Hydrochloride Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Tiapride Hydrochloride Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Tiapride Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Tiapride Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Tiapride Hydrochloride Tablets Market Size by Country
    • 10.3.1 South America Tiapride Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Tiapride Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tiapride Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Tiapride Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Tiapride Hydrochloride Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Tiapride Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Tiapride Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Tiapride Hydrochloride Tablets Market Drivers
  • 12.2 Tiapride Hydrochloride Tablets Market Restraints
  • 12.3 Tiapride Hydrochloride Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tiapride Hydrochloride Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tiapride Hydrochloride Tablets
  • 13.3 Tiapride Hydrochloride Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tiapride Hydrochloride Tablets Typical Distributors
  • 14.3 Tiapride Hydrochloride Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tiapride Hydrochloride Tablets market size was valued at US$ 175 million in 2025 and is forecast to a readjusted size of US$ 229 million by 2032 with a CAGR of 4.0% during review period.
    Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain. It is used to treat a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly.
    This report is a detailed and comprehensive analysis for global Tiapride Hydrochloride Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tiapride Hydrochloride Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tiapride Hydrochloride Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tiapride Hydrochloride Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tiapride Hydrochloride Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tiapride Hydrochloride Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tiapride Hydrochloride Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Nihon Generic, Sawai Pharmaceutical, Tasly Pharmaceuticals, Grand Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tiapride Hydrochloride Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    100mg
    50mg
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Astellas Pharma
    Nihon Generic
    Sawai Pharmaceutical
    Tasly Pharmaceuticals
    Grand Pharmaceutical
    Jiangsu Nhwa Pharmaceutical
    Tianjin Pharmaceutical Da Ren Tang Group
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tiapride Hydrochloride Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tiapride Hydrochloride Tablets, with price, sales quantity, revenue, and global market share of Tiapride Hydrochloride Tablets from 2021 to 2026.
    Chapter 3, the Tiapride Hydrochloride Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tiapride Hydrochloride Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tiapride Hydrochloride Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tiapride Hydrochloride Tablets.
    Chapter 14 and 15, to describe Tiapride Hydrochloride Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now